HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Gynecological cancers, affecting the female reproductive system, include ovarian, cervical, uterine, vaginal, and vulvar cancers. These cancers often go undetected in their early stages, leading to poorer prognoses. Research efforts are concentrating on identifying novel biomarkers that can facilitate early diagnosis and increase survival rates. In addition, advancements in surgical techniques, radiation therapy, and chemotherapy have led to better management of these cancers. However, there remains a need for more personalized treatments, particularly for advanced-stage diseases. Immunotherapy and targeted therapies are on the horizon, offering hope for more effective treatments with fewer side effects. A better understanding of the genetic and molecular underpinnings of these cancers is essential for developing tailored therapeutic strategies.
